Metformin Beneficial in Lung Cancer Patients With Overweight, Obesity
By Elana Gotkine HealthDay Reporter
TUESDAY, Dec. 10, 2024 -- In non-small cell lung cancer (NSCLC) patients with overweight or obesity, metformin may improve lung cancer-specific clinical outcomes, according to a study published online Nov. 19 in the Journal of the National Cancer Institute.
Randall J. Smith Jr., Ph.D., from the Roswell Park Comprehensive Cancer Center in Buffalo, New York, and colleagues retrospectively analyzed two clinical cohorts and employed contemporary mouse models to examine whether metformin could benefit NSCLC patients with overweight and obesity. One cohort included NSCLC patients with overweight body mass index (BMI) and nonoverweight BMI (511 and 232 individuals, respectively) who underwent lobectomy, and the second examined the effect of metformin on progression-free survival (PFS) after immune checkpoint inhibitor treatment in 284 NSCLC patients with overweight BMI versus 184 NSCLC patients with nonoverweight BMI.
The researchers found that in patients with overweight, there was an association for metformin with increased recurrence-free survival after lobectomy (hazard ratio, 0.47). In diet-induced obese mouse models, metformin corrected accelerated tumor growth in a lymphocyte-specific manner, while reversing certain mechanisms of immune suppression potentiated by obesity. In obese mice, programmed cell death 1 blockade coupled with metformin was more effective at limiting tumor burden; in patients with overweight on immunotherapy, metformin correlated with PFS (hazard ratio, 0.60).
"Our findings demonstrate a need for prospective studies of metformin's effects on high BMI individuals with advanced lung cancer, especially the growing population receiving checkpoint blockade therapy," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted December 2024
Read this next
ADA: Weight Loss, Type 2 Diabetes Remission Up With Replacing Diet Drinks With Water
WEDNESDAY, June 25, 2025 -- For adult women with overweight or obesity and type 2 diabetes (T2D), replacing diet beverages (DBs) with water is associated with greater weight loss...
Self-Esteem Scores Soar One Year After Metabolic, Bariatric Surgery
TUESDAY, June 24, 2025 -- Self-esteem scores increase after metabolic and bariatric surgery (MBS), with greater improvement in scores for those with higher postoperative weight...
Minor Complications Up for Black Patients After Weight-Loss Surgery
MONDAY, June 23, 2025 -- Black patients have a higher incidence of minor complications after metabolic and bariatric surgery, according to a study presented at the annual meeting...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.